
The study results will help to identify dosing levels for future clinical trials

The study results will help to identify dosing levels for future clinical trials

Working smarter, not harder, to benefit patients

Orbis advances cataract surgery training in low-resource areas with technology

Experts from around the globe converged in San Francisco, California

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

Restoration and regeneration represent a new paradigm

A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD

In recognition of global Geographic Atrophy Week, Prevent Blindness is providing free educational resources on GA for patients, care partners and healthcare professionals


At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

Data show transfection in both eyes despite unilateral injection

In early November, the EU MDR issued a CE mark certification for RetInSight’s AI-based geographic atrophy monitor

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

Moving toward eliminating drug and chemical safety testing in animals

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

Patients who received digital education demonstrated a better understanding of their disease and its management

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials

Dr Marco Zarbin emphasises the importance of defining “active disease”

In the clinical trial, Oxurion’s novel PKal Inhibitor, THR-149, did not meet its primary endpoint

Infrastructure across Europe needs a major overhaul to optimise education and patient access in groundbreaking treatments